Viewing Study NCT03664973



Ignite Creation Date: 2024-05-06 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 12:53 PM
Study NCT ID: NCT03664973
Status: UNKNOWN
Last Update Posted: 2019-05-09
First Post: 2018-09-02

Brief Title: Serratus Plane Block for Rib Fractures
Sponsor: Arcispedale Santa Maria Nuova-IRCCS
Organization: Arcispedale Santa Maria Nuova-IRCCS

Study Overview

Official Title: Effect of the Serratus Plane Block on the Outcome in Patient With Multiple Rib Fractures A Prospective Randomized Controlled Trial
Status: UNKNOWN
Status Verified Date: 2019-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients with ipsilateral multiple rib fractures will be randomized to receive either a single-shot ultrasound-guided serratus plane block or a continuous serratus plane block within 24h from the chest trauma Primary outcome is the difference in forced respiratory volume FEV1 at 72h
Detailed Description: Patients admitted in emergency department with a chest trauma and ipsilateral multiple rib fractures will be randomized as described above All patients will receive the serratus block with a ropivacaine 037 solution 20 ml Then they will randomized to receive either a peripheral catheter placed above the 5th rib on the middle axillary line or nothing In all patients postoperative analgesia also include Paracetamol 1g IV each 6h and a patient controlled analgesia PCA of morphine set out as follow bolus 1 mg loch out 15 min max 4 boluses each hour In all patients an arterial blood sample for gas analysis and a FEV1 will be achieved before the block after 1 hour and at 72h

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None